Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthma. [electronic resource]
Producer: 20100106Description: 859-65 p. digitalISSN:- 1938-2707
- Administration, Inhalation
- Administration, Oral
- Adolescent
- Anti-Asthmatic Agents -- administration & dosage
- Antibodies, Anti-Idiotypic
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Asthma -- diagnosis
- Child
- Drug Therapy, Combination
- Female
- Forced Expiratory Volume -- drug effects
- Glucocorticoids -- administration & dosage
- Humans
- Hypersensitivity -- complications
- Male
- Office Visits -- statistics & numerical data
- Omalizumab
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.